Aspire Congestion and Cough Relief DM Softgels is a Oral Capsule, Liquid Filled in the Human Otc Drug category. It is labeled and distributed by Aspire Pharmaceuticals Inc. The primary component is Dextromethorphan Hydrobromide; Guaifenesin.
| Product ID | 81013-104_dbc517f5-ac4f-6ad3-e053-2a95a90a5aee |
| NDC | 81013-104 |
| Product Type | Human Otc Drug |
| Proprietary Name | Aspire Congestion and Cough Relief DM Softgels |
| Generic Name | Aspire Congestion And Cough Relief Dm Softgels |
| Dosage Form | Capsule, Liquid Filled |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-04-14 |
| Marketing Category | OTC MONOGRAPH FINAL / |
| Application Number | part341 |
| Labeler Name | Aspire Pharmaceuticals Inc |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
| Active Ingredient Strength | 10 mg/1; mg/1 |
| Pharm Classes | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |